Annual CFO
-$11.95 M
+$7.64 M+39.01%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual cash flow from operations is -$11.95 million, with the most recent change of +$7.64 million (+39.01%) on December 31, 2023.
- During the last 3 years, VVOS annual CFO has fallen by -$6.27 million (-110.32%).
- VVOS annual CFO is now -124.81% below its all-time high of -$5.31 million, reached on December 31, 2018.
Performance
VVOS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.19 M
-$1.14 M-37.37%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly cash flow from operations is -$4.19 million, with the most recent change of -$1.14 million (-37.37%) on September 30, 2024.
- Over the past year, VVOS quarterly CFO has stayed the same.
- VVOS quarterly CFO is now -858.34% below its all-time high of -$436.90 thousand, reached on March 1, 2020.
Performance
VVOS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$12.50 M
-$1.39 M-12.48%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM cash flow from operations is -$12.50 million, with the most recent change of -$1.39 million (-12.48%) on September 30, 2024.
- Over the past year, VVOS TTM CFO has stayed the same.
- VVOS TTM CFO is now -2760.84% below its all-time high of -$436.90 thousand, reached on March 1, 2020.
Performance
VVOS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VVOS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.0% | 0.0% | 0.0% |
| 3 y3 years | -110.3% | -3.2% | +17.9% |
| 5 y5 years | -124.8% | -8.4% | -37.3% |
VVOS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.0% | -66.4% | +31.2% | -14.4% | +39.6% |
| 5 y | 5-year | -123.7% | +39.0% | -858.3% | +31.2% | -2760.8% | +39.6% |
| alltime | all time | -124.8% | +39.0% | -858.3% | +31.2% | -2760.8% | +39.6% |
Vivos Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.19 M(+37.4%) | -$12.50 M(+12.5%) |
| Jun 2024 | - | -$3.05 M(+21.1%) | -$11.11 M(+1.7%) |
| Mar 2024 | - | -$2.52 M(-8.4%) | -$10.92 M(-8.6%) |
| Dec 2023 | -$11.95 M(-39.0%) | -$2.75 M(-1.9%) | -$11.95 M(-2.1%) |
| Sep 2023 | - | -$2.80 M(-2.1%) | -$12.20 M(-20.0%) |
| Jun 2023 | - | -$2.86 M(-19.2%) | -$15.24 M(-10.6%) |
| Mar 2023 | - | -$3.54 M(+18.0%) | -$17.04 M(-13.0%) |
| Dec 2022 | -$19.59 M | -$3.00 M(-48.6%) | -$19.59 M(-5.4%) |
| Sep 2022 | - | -$5.84 M(+25.3%) | -$20.71 M(+9.4%) |
| Jun 2022 | - | -$4.66 M(-23.3%) | -$18.93 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.08 M(+47.5%) | -$17.96 M(+14.1%) |
| Dec 2021 | -$15.73 M(+177.0%) | -$4.12 M(+1.6%) | -$15.73 M(+3.3%) |
| Sep 2021 | - | -$4.06 M(+9.9%) | -$15.23 M(+28.6%) |
| Jun 2021 | - | -$3.69 M(-4.3%) | -$11.85 M(+30.1%) |
| Mar 2021 | - | -$3.86 M(+6.7%) | -$9.10 M(+60.3%) |
| Dec 2020 | -$5.68 M(+6.4%) | -$3.62 M(+436.5%) | -$5.68 M(+175.5%) |
| Sep 2020 | - | -$674.40 K(-29.1%) | -$2.06 M(+48.6%) |
| Jun 2020 | - | -$950.60 K(+117.6%) | -$1.39 M(+217.6%) |
| Mar 2020 | - | -$436.90 K | -$436.90 K |
| Dec 2019 | -$5.34 M(+0.5%) | - | - |
| Dec 2018 | -$5.31 M | - | - |
FAQ
- What is Vivos Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Vivos Therapeutics?
- What is Vivos Therapeutics annual CFO year-on-year change?
- What is Vivos Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly CFO year-on-year change?
- What is Vivos Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Vivos Therapeutics?
- What is Vivos Therapeutics TTM CFO year-on-year change?
What is Vivos Therapeutics annual cash flow from operations?
The current annual CFO of VVOS is -$11.95 M
What is the all time high annual CFO for Vivos Therapeutics?
Vivos Therapeutics all-time high annual cash flow from operations is -$5.31 M
What is Vivos Therapeutics annual CFO year-on-year change?
Over the past year, VVOS annual cash flow from operations has changed by +$7.64 M (+39.01%)
What is Vivos Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VVOS is -$4.19 M
What is the all time high quarterly CFO for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly cash flow from operations is -$436.90 K
What is Vivos Therapeutics quarterly CFO year-on-year change?
Over the past year, VVOS quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM cash flow from operations?
The current TTM CFO of VVOS is -$12.50 M
What is the all time high TTM CFO for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM cash flow from operations is -$436.90 K
What is Vivos Therapeutics TTM CFO year-on-year change?
Over the past year, VVOS TTM cash flow from operations has changed by $0.00 (0.00%)